Stock AT1 ATOMO DIAGNOSTICS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Atomo Diagnostics Limited

Equities

AT1

AU0000080327

Advanced Medical Equipment & Technology

Market Closed - Australian S.E.
Other stock markets
 02:10:42 2024-05-01 am EDT 		5-day change 1st Jan Change
0.03 AUD -6.25% Intraday chart for Atomo Diagnostics Limited -3.23% +36.36%
Apr. 30 Transcript : Atomo Diagnostics Limited, Q3 2024 Earnings Call, Apr 30, 2024
Apr. 15 Atomo Diagnostics Wins AU$570,000 HIV Self-Tests Order MT

Valuation

Fiscal Period: June 2020 2021 2022 2023
Capitalization 1 190.8 104.7 31.97 12.56
Enterprise Value (EV) 1 163.7 86.87 19.34 6.344
P/E ratio -13.1 x -17.3 x -5.58 x -1.26 x
Yield - - - -
Capitalization / Revenue 35.5 x 15.6 x 2.59 x 4.94 x
EV / Revenue 30.5 x 12.9 x 1.57 x 2.49 x
EV / EBITDA -102 x -19.5 x -5.33 x -0.77 x
EV / FCF -15.2 x -10.1 x -7.59 x -2.68 x
FCF Yield -6.56% -9.94% -13.2% -37.3%
Price to Book 5.53 x 3.5 x 1.29 x 0.85 x
Nbr of stocks (in thousands) 561,078 566,198 570,891 570,891
Reference price 2 0.3400 0.1850 0.0560 0.0220
Announcement Date 8/30/20 8/27/21 8/25/22 8/23/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 0.2872 0.5397 5.369 6.716 12.34 2.544
EBITDA 1 -5.779 -4.569 -1.612 -4.457 -3.632 -8.277
EBIT 1 -6.108 -5.13 -2.221 -5.406 -5.095 -9.569
Operating Margin -2,126.47% -950.46% -41.37% -80.5% -41.31% -376.17%
Earnings before Tax (EBT) 1 -7.2 -5.861 -9.218 -6.021 -5.707 -9.958
Net income 1 -4.9 -5.055 -9.218 -6.021 -5.707 -9.958
Net margin -1,705.89% -936.59% -171.7% -89.66% -46.26% -391.46%
EPS 2 -0.0186 -0.0174 -0.0259 -0.0107 -0.0100 -0.0174
Free Cash Flow 1 -6.134 -1.649 -10.74 -8.635 -2.55 -2.365
FCF margin -2,135.57% -305.53% -199.98% -128.57% -20.67% -92.98%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/14/20 4/14/20 8/30/20 8/27/21 8/25/22 8/23/23
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 9.5 8.48 - - - -
Net Cash position 1 - - 27 17.9 12.6 6.22
Leverage (Debt/EBITDA) -1.643 x -1.856 x - - - -
Free Cash Flow 1 -6.13 -1.65 -10.7 -8.63 -2.55 -2.37
ROE (net income / shareholders' equity) 202% 97.6% -63.6% -18.7% -20.8% -50.3%
ROA (Net income/ Total Assets) -38.9% -46.4% -6.59% -9.89% -10.8% -27.8%
Assets 1 12.59 10.88 140 60.89 52.74 35.88
Book Value Per Share 2 -0.0200 -0.0200 0.0600 0.0500 0.0400 0.0300
Cash Flow per Share 2 0.0100 0.0100 0.0500 0.0300 0.0200 0.0100
Capex 1 0.55 0.74 0.82 3.12 1.39 0.06
Capex / Sales 192.37% 137.09% 15.25% 46.46% 11.29% 2.36%
Announcement Date 4/14/20 4/14/20 8/30/20 8/27/21 8/25/22 8/23/23
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
ATOMO DIAGNOSTICS LIMITED Stock Atomo Diagnostics Limited
+36.36% 13.28M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.26% 217B
DANAHER CORPORATION Stock Danaher Corporation
+6.08% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+9.68% 131B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+23.81% 106B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-0.95% 62.16B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+9.94% 51.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.81% 50.89B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-1.54% 40.16B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+0.75% 34.79B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. AT1 Stock
  4. Financials Atomo Diagnostics Limited